Articles published in Journal of Stem Cell Research & Therapy have been cited by esteemed scholars and scientists all around the world. Journal of Stem Cell Research & Therapy has got h-index 33, which means every article in Journal of Stem Cell Research & Therapy has got 33 average citations.

Following are the list of articles that have cited the articles published in Journal of Stem Cell Research & Therapy.

Journal total citations count 6793
Journal impact factor 1.64
Journal 5 years impact factor 1.70
Journal cite score 11.56
Journal h-index 33
Important citations

Alcohol and Cancer Stem Cells

Alcohol and Cancer Stem Cells

In Vivo Outcome of Homology-Directed Repair at the HBB Gene in HSC Using Alternative Donor Template Delivery Methods

Impact of perioperative pain management on cancer recurrence: an ASRA/ESRA special article

The role of TRIM family proteins in the regulation of cancer stem cell self-renewal

The role of TRIM family proteins in the regulation of cancer stem cell self-renewal

Glioblastoma Stem Cell-Derived Exosomes Enhance Stemness and Tumorigenicity of Glioma Cells by Transferring Notch1 Protein

Editing the sickle cell disease mutation in human hematopoietic stem cells: comparison of endonucleases and homologous donor templates

Hypoxia Induces the Acquisition of Cancer Stem-like Phenotype Via Upregulation and Activation of Signal Transducer and Activator of Transcription-3 (STAT3) in MDA-MB-231, a Triple Negative Breast Cancer Cell Line

Increased Cellular Levels of MicroRNA-9 and MicroRNA-221 Correlate with Cancer Stemness and Predict Poor Outcome in Human Breast Cancer

Human genome-edited hematopoietic stem cells phenotypically correct Mucopolysaccharidosis type I

Editing a ?-globin repressor binding site restores fetal hemoglobin synthesis and corrects the sickle cell disease phenotype

Lentiviral and genome-editing strategies for the treatment of ?-hemoglobinopathies

The delivery challenge: fulfilling the promise of therapeutic genome editing

Priming human repopulating hematopoietic stem and progenitor cells for Cas9/sgRNA gene targeting

Genetic engineering of hematopoiesis: current stage of clinical translation and future perspectives

Correction to: Treating primary immunodeficiencies with defects in NK cells: from stem cell therapy to gene editing

Disruption of the BCL11A erythroid enhancer reactivates fetal hemoglobin in erythroid cells of patients with ?-thalassemia major

 Cyclosporine H overcomes innate immune restrictions to improve lentiviral transduction and gene editing in human hematopoietic stem cells

Tregopathies: monogenic diseases resulting in regulatory T-cell deficiency